GlassScriptPhysician profile
Aaref Badshah
NPI 1548438740
$12,228.87
in general payments reported to CMS, 2019-2025
31 companies · $2,572 in 2025
The $2,572 reported for 2025 was more than what a typical Clinical Cardiac Electrophysiology provider received nationally (typical 2025 total: $2,477).
See the full distribution for Clinical Cardiac Electrophysiology
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,720 · 2020: $1,522 · 2021: $326 · 2022: $538 · 2023: $476 · 2024: $4,076 · 2025: $2,572.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,123 · Consulting Fee: $2,000 · Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $1,200 · Travel and Lodging: $800.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,122.88 |
| Consulting Fee | $2,000.00 |
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $1,200.00 |
| Travel and Lodging | $800.06 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biotronik INC. | $7,077.81 | 2019-2025 | Selectra, Solia, Amvia Edge |
| Boston Scientific Corporation | $1,138.41 | 2019-2025 | S-Icd System Magnet |
| Kestra Medical Technology Services, INC. | $458.62 | 2022-2025 | Assure Wcd |
| Endologix LLC | $369.62 | 2019-2025 | Alto Abdominal Stent Graft System, Afx2 Bifurcated Endograft System |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $341.06 | 2020-2025 | Lifevest |
| Medtronic, INC. | $302.16 | 2021-2025 | Azure Xt Dr Mri Surescan, Arctic Front Advance, Micra |
| Abbott Laboratories | $269.79 | 2022-2025 | Viewmate, Cardiomems, Amplatzer Amulet |
| Cordis US Corp. | $249.35 | 2025 | Mynx Control Venous |
| Novartis Pharmaceuticals Corporation | $200.98 | 2021-2025 | |
| Sanofi-Aventis U.S. LLC | $192.19 | 2019-2024 | |
| Janssen Pharmaceuticals, INC | $181.55 | 2019-2022 | |
| Medtronic Vascular, INC. | $158.04 | 2019 | |
| Biosense Webster, INC. | $149.72 | 2019 | |
| Philips North America LLC | $132.30 | 2024 | (9520) Igt Devices Undivided |
| Astrazeneca Pharmaceuticals LP | $116.30 | 2020-2022 |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kiniksa Pharmaceuticals, LTD. | $109.26 | 2021-2023 | Arcalyst |
| Merck Sharp & Dohme LLC | $106.58 | 2022-2024 | Verquvo |
| Pfizer INC. | $102.16 | 2022-2025 | |
| Amgen INC. | $89.36 | 2020-2022 | |
| Baxter Healthcare | $88.86 | 2022-2025 | Hillrom - Carnation Ambulatory Monitor |
| Alnylam Pharmaceuticals INC. | $86.30 | 2023-2025 | Onpattro |
| United Therapeutics Corporation | $69.21 | 2024-2025 | Tyvaso, Tyvaso |
| Impulse Dynamics (USA) INC. | $62.42 | 2025 | Optimizer |
| E.R. Squibb & Sons, L.L.C. | $56.01 | 2024-2025 | Camzyos |
| Cvrx, INC. | $31.49 | 2024-2025 | Barostim Neo System |
| Cleerly, INC. | $29.81 | 2025 | Cleerly Labs, Cleerly Ischemia |
| Cardiva Medical, INC. | $24.49 | 2025 | Cardiva Vascade Mvp Vvcs 6-12f |
| Atricure, INC. | $18.08 | 2022 | |
| Novo Nordisk INC | $16.94 | 2025 | Wegovy |
2 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Aaref Badshah listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.